ADVERTISE WITH US - Download Rate Card.
TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) — Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), today announced the launch of its first oral dose-metered spray, Emblem Atmosphere. Designed with patients’ needs in mind, Atmosphere ensures a precise dose with each spray and a convenient medication delivery system. Atmosphere is available in four different formulations, offering patients and healthcare professionals choice to meet a variety of health goals.
“The launch of Atmosphere is further reinforcement of Emblem’s core focus on creating new, innovative and unique products that help patients – Emblem’s first and foremost priority. Atmosphere oral sprays were developed to help patients better manage their symptoms through precise dosing of their cannabis medication,” said Nick Dean, CEO, Emblem Corp. “This latest product launch is a testament to the incredible work being done by Emblem’s medical division. Precise dosing in each oral spray allows patients to easily track medication use and adjust use as needed. Atmosphere sprays also provide patients with a cleaner and more discreet experience.”
Atmosphere oral dose-metered sprays use the same formulations as Emblem’s line of cannabis oils including 0:20 CBD Oil, 12:20 Balanced CBD Oil, 20:0 Indica Dominant Oil and 20:0 Sativa Dominant Oil. Each formulation is chemovar-specific to ensure product consistency. Atmosphere sprays are developed using MCT oil, a pharmaceutical-grade carrier oil that is flavour-neutral, odourless and shelf-stable.
The oral sprays are intended to be administered sublingually, with each spray delivering 0.1 ml of oil, or roughly 2 mg of active ingredients. Atmosphere comes in a 15 ml cannister, with 150 sprays per bottle.
For more information visit https://emblemcannabis.com/collection/extracts/.